Effects of Rut-bpy (Cis-[Ru(bpy) 2(SO 3)(NO)]PF 6), a novel nitric oxide donor, in L-NAME-induced hypertension in rats;Efeitos do Rut-bpy (Cis-[Ru(bpy) 2(SO 3)(NO)]PF 6), um novo doador de óxido nítrico, na hipertensão induzida com L-NAME em ratos

Acta Cirurgica Brasileira

Volumn 26, Issue SUPPL. 1, 2011, Pages 57-59

  Campelo, Marcio Wilker Soares ^a   Campelo, Ana Paula Bomfim Soares ^a   de França Lopes, Luiz Gonzaga ^a   dos Santos, Armenio Aguiar ^b   Guimarães, Sergio Botelho ^a   de Vasconcelos, Paulo Roberto Leitão ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Faculty of Medicine   (Brazil)

Author keywords

Blood pressure; Hypertension; Nitric oxide; Rats; Ruthenium

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE DONOR; RUTHENIUM DERIVATIVE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; COORDINATION COMPLEXES; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; ORGANOMETALLIC COMPOUNDS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RUTHENIUM; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 80053481693     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502011000700012     Document Type: Article

References (15)

1. Puddu P, Puddu GM, Zaca F, Muscari A. Endothelial dysfunction in hypertension. Acta Cardiol. 2000;55(4):221-32.
2. Ford PC, Wink DA, Stanbury DM. Autoxidation kinetics of aqueous nitric oxide. FEBS Lett. 1993;326(1-3):1-3.
3. Wink DA, Darbyshire JF, Nims RW, Saavedra JE, Ford PC. Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction. Chem Res Toxicol. 1993;6(1):23-7.
4. Wink DA, Grisham MB, Mitchell JB, Ford PC. Direct and indirect effects of nitric oxide in chemical reactions relevant to biology. Methods Enzymol. 1996;268:12-31.
5. Gaitani CM, Melo CC, Lunardi NC, Oliveira FS, Silva RS, Bendhack LM. Hypotensive effect of the nitrosyl ruthenium complex nitric oxide donorin renal hypertensive rats. Nitric Oxide. 2009;20(3):195-9.
6. Cerqueira JB, Silva LF, Lopes LG, Moraes ME, Nascimento NR, Relaxation of rabbit corpus cavernosum smooth muscle and aortic vascular endothelium induced by new nitric oxide donor substances of the nitrosyl-ruthenium complex. Int Braz J Urol. 2008;34(5):638-46.
7. Bonaventura D, de Lima RG, Vercesi JA, da Silva RS, Bendhack LM. Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex. Vasc Pharmacol. 2007;46(3):215-22.
8. Silva FO, Araujo SX, Holanda AK, Meyer E, Sales FA, Diogenes IC, Carvalho IM, Moreira IS, Lopes LGF. Synthesis, Characterization, and NO Release Study of the cis- and trans-[Ru(Bpy)2(SO3)(NO)]+ Complexes. Eur J Inorg Chem. 2006:1434-48.
9. Silva JJN, Guedes PM, Zottis A, Balliano TL, Silva FON, Lopes LGF, Ellena J, Oliva G, Andricopulo AD, Franco DW, Silva JS. Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity. Br J Pharmacol.2010;160(2):260-9.
10. Ignarro LJ, Cirino G, Casini A, Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol.1999;34(6):879-86.
11. Fricker SP, Slade E, Powell NA, Vaughan OJ, Henderson GR, Murrer BA, Megson IL, Bisland SK, Flitney FW. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases. Br J Pharmacol. 1997;122(7):1441-9.
12. Hutchings SR, Song D, Fricker SP, Pang CC. The ruthenium-based nitric oxide scavenger, AMD6221, augments cardiovascular responsiveness to noradrenaline in rats with streptozotocin-induced diabetes. Eur J Pharmacol. 2005;528(1-3):132-6.
13. Baylis C, Harton P, Engels K. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol.1990;1(6):875-81.
14. Anderson TJ, Meredith IT, Ganz P, Selwyn AP, Yeung AC. Nitric oxide and nitrovasodilators: similarities, differences and potential interactions. J Am Coll Cardiol. 1994;24(2):555-66.
15. Fricker SP, Slade E, Powell NA, Vaughan OJ, Henderson GR, Murrer BA, Megson IL, Bisland SK, Flitney FW. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxide-mediated diseases. Br J Pharmacol. 1997;122(7):1441-9.